MedTrace Logo

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

NCT03739476 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2025-05-22

No results posted yet for this study

Summary

Double blinded Clinical trial to test efficacy of Quetiapine versus placebo in reducing postoperative delirium in high risk surgical patients after three days of treatment.

Conditions

  • Postoperative Delirium

Interventions

DRUG

Quetiapine 25 milligrams capsule

Compare the incidence of postoperative delirium.

DRUG

Placebo oral capsule

Compare the incidence of postoperative delirium.

Sponsors & Collaborators

  • Instituto de Investigación Biomédica de Salamanca

    collaborator OTHER

  • Grupo Español de Rehabilitación Multimodal

    collaborator OTHER

  • Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

    lead OTHER

Principal Investigators

  • Elisa Sanchez-Barrado, MD · Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-13
Primary Completion
2020-04-02
Completion
2020-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03739476 on ClinicalTrials.gov